(2S,3R,4R,5R,6R)-3-Acetamido-6-(acetoxymethyl)tetrahydro-2H-pyran-2,4,5-triyl triacetate, 98.0%, 25g

N-[(4-Fluorophenyl)methyl]piperazine-1-carboxamide hydrochloride, 1g

5-Methyl-2-(3-trifluoromethyl-phenyl)-2,4-dihydro-pyrazol-3-one, 2.5g

1,2-O-Isopropylidene-alpha-D-xylofuranose>98.0%(GC)5g

2-(((3aR,4S,6R,6aS)-6-((5-amino-6-chloro-2-(propylsulfonyl)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-4H-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethan-1-ol, 97%, 10mg

4-(2-chlorobenzoyl)-8-ethyl-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

ROTI® SampleLyse Soft Tissue 2, 250 pièces 250 pièces

4,4'-Bipyridine -1,1'-dioxide, 97.0%, 10g

7-Aminoheptanoic acid, 97.0%, 5g

Oseltamivir phosphate, 98.0%, 25g

3-Benzyl-3-azabicyclo[3.1.0]hexane-1-carboxylic acid, 95.0%, 100mg

2-Amino-3-bromophenol, 95.0%, 5g

2',4'-Dichlorovalerophenone>95.0%(GC)25g